» Articles » PMID: 37016404

Intrinsic Signalling Factors Associated with Cancer Cell-cell Fusion

Overview
Publisher Biomed Central
Date 2023 Apr 4
PMID 37016404
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular fusion e.g. between cancer cells and normal cells represents a stepwise process that is tightly regulated. During a pre-hybrid preparation program somatic cells and/or cancer cells are promoted to a pro-fusogenic state as a prerequisite to prepare a fusion process. A pro-fusogenic state requires significant changes including restructure of the cytoskeleton, e.g., by the formation of F-actin. Moreover, distinct plasma membrane lipids such as phosphatidylserine play an important role during cell fusion. In addition, the expression of distinct fusogenic factors such as syncytins and corresponding receptors are of fundamental importance to enable cellular mergers. Subsequent hybrid formation and fusion are followed by a post-hybrid selection process. Fusion among normal cells is important and often required during organismal development. Cancer cells fusion appears more rarely and is associated with the generation of new cancer hybrid cell populations. These cancer hybrid cells contribute to an elevated tumour plasticity by altered metastatic behaviour, changes in therapeutic and apoptotic responses, and even in the formation of cancer stem/ initiating cells. While many parts within this multi-step cascade are still poorly understood, this review article predominantly focusses on the intracellular necessities for fusion among cancer cells or with other cell populations of the tumour microenvironment. Video Abstract.

Citing Articles

Mapping cell-cell fusion at single-cell resolution.

Gardner A, Zheng L, Howland K, Saunders A, Ramirez A, Parker P bioRxiv. 2025; .

PMID: 39896473 PMC: 11785005. DOI: 10.1101/2024.12.11.627873.


Fusion of tumor cells and mesenchymal stem/stroma cells: a source of tumor heterogeneity, evolution and recurrence.

Liu Z, Wang Y, Peng Z, Li H, Wang H, Wu Y Med Oncol. 2025; 42(2):52.

PMID: 39838167 DOI: 10.1007/s12032-024-02595-z.


Cell-cell fusion: To lose one life and begin another.

Whitlock J, Chernomordik L Bioessays. 2024; 47(2):e2400206.

PMID: 39506368 PMC: 11755699. DOI: 10.1002/bies.202400206.


Intercellular Molecular Transfer Mediated by Extracellular Vesicles in Cancer.

Adnani L, Rak J Results Probl Cell Differ. 2024; 73:327-352.

PMID: 39242385 DOI: 10.1007/978-3-031-62036-2_14.


Transcription of Endogenous Retroviruses: Broad and Precise Mechanisms of Control.

Jarosz A, Halo J Viruses. 2024; 16(8).

PMID: 39205286 PMC: 11359688. DOI: 10.3390/v16081312.


References
1.
Gast C, Silk A, Zarour L, Riegler L, Burkhart J, Gustafson K . Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv. 2018; 4(9):eaat7828. PMC: 6135550. DOI: 10.1126/sciadv.aat7828. View

2.
Brukman N, Nakajima K, Valansi C, Flyak K, Li X, Higashiyama T . A novel function for the sperm adhesion protein IZUMO1 in cell-cell fusion. J Cell Biol. 2022; 222(2). PMC: 9671554. DOI: 10.1083/jcb.202207147. View

3.
Zhou X, Platt J . Molecular and cellular mechanisms of mammalian cell fusion. Adv Exp Med Biol. 2011; 713:33-64. DOI: 10.1007/978-94-007-0763-4_4. View

4.
Bakhoum S, Kabeche L, Compton D, Powell S, Bastians H . Mitotic DNA Damage Response: At the Crossroads of Structural and Numerical Cancer Chromosome Instabilities. Trends Cancer. 2017; 3(3):225-234. PMC: 5518619. DOI: 10.1016/j.trecan.2017.02.001. View

5.
Bi P, Ramirez-Martinez A, Li H, Cannavino J, McAnally J, Shelton J . Control of muscle formation by the fusogenic micropeptide myomixer. Science. 2017; 356(6335):323-327. PMC: 5502127. DOI: 10.1126/science.aam9361. View